US Markets Closed

AI-assisted · Not financial adviceNot advice

AI-assisted · Not financial advice.

US Markets Closed

AI-assisted · Not financial adviceNot advice

US Markets Closed

AI-assisted · Not financial adviceNot advice

$MRNA

Name: MRNA (Moderna) — Market Sentiment & Discussion
Creator: MarketMind
License: https://stockmarketsentimentai.com/methodology

Moderna· 8/26/2026, 11:19:55 AM

Three questions about MRNA

Buy, wait, or sell today?: Data unavailable right now
Clean chart pattern?: Pattern forming — Pullback in uptrend
Passes the small-cap health check?: Not applicable — a large-cap index name, outside this screen

Analyst & Event Activity

Analyst Rating Changes

Aug 25Wolfe ResearchUnderperform → Peer Perform

Aug 19William BlairMarket Perform → Outperform

Aug 24BarclaysEqual Weight (reiterated)

Aug 21JP MorganUnderweight (reiterated)

Aug 20UBSNeutral (reiterated)

Aug 20Goldman SachsNeutral (reiterated)

Aug 20Morgan StanleyEqual Weight (reiterated)

Options positioning: Bullish — More betting on upside (1.6× more call than put volume today). Unusual bets on $160 upside — 9× normal activity. analysts: 8 buy vs 4 sell.

Reddit: CautiousAttention: Surging

Community Take (7D)

Retail sentiment is excited about MRNA's cancer vaccine potential, but concerns about sustainability and insider trading exist. News of a surge in shares due to pipeline updates indicates strong interest, yet caution is advised.

The Story

News Summary

Moderna shares surge on pipeline updates

Key Events

Jun 29:Moderna shares rose after announcing a strategy to expand into oncology.
Jun 30:Moderna announced major updates on an mRNA-based flu vaccine.
Jul 1:Moderna revealed its strategy for using mRNA to combat cancer and rare diseases.

Sentiment: 80% bullish / 20% neutral (early) → 90% bullish / 10% neutral (late)

Impact: The narrative evolved from initial excitement over new product strategies to a strong market rally, highlighting investor optimism in Moderna's future prospects.

Analyst ConsensusHold (27 analysts)

Target: $108 avg (+125% upside)

7 Buy · 16 Hold · 4 Sell

Signal

Bullish

Confidence

80%

Based on curated news sources (not retail comments)

Over the last 7 days: Moderna is experiencing strong market interest and positive developments in its product pipeline.

SentimentCautious Optimism

AnalysisHype

Bullish Factors

✓Moderna's shares rose significantly, hitting a 52-week high after expanding its mRNA platform into new therapeutic areas.
✓Positive market response to new pipeline updates and encouraging influenza vaccine data.

Risk Factors

No bear risks identified

Analyst target

125% upside · 11 analysts · $25–$245 range

▲ $108

Insiders (90d)

0 buys, 7 sells

Last: SELL Aug 5· 21d ago

▼Net selling $35.2M

Rules-based signal view →

Analyze with AI yahoo!finance Reddit Answers

AI-assisted · Not financial advice.

$MRNA - Moderna | MarketMind | MarketMind

$MRNA

Moderna· 8/26/2026, 11:19:55 AM

Three questions about MRNA

Buy, wait, or sell today?: Data unavailable right now
Clean chart pattern?: Pattern forming — Pullback in uptrend
Passes the small-cap health check?: Not applicable — a large-cap index name, outside this screen

Analyst & Event Activity

Analyst Rating Changes

Aug 25Wolfe ResearchUnderperform → Peer Perform

Aug 19William BlairMarket Perform → Outperform

Aug 24BarclaysEqual Weight (reiterated)

Aug 21JP MorganUnderweight (reiterated)

Aug 20UBSNeutral (reiterated)

Aug 20Goldman SachsNeutral (reiterated)

Aug 20Morgan StanleyEqual Weight (reiterated)

Options positioning: Bullish — More betting on upside (1.6× more call than put volume today). Unusual bets on $160 upside — 9× normal activity. analysts: 8 buy vs 4 sell.

Reddit: CautiousAttention: Surging

Community Take (7D)

The Story

News Summary

Moderna shares surge on pipeline updates

Key Events

Jun 29:Moderna shares rose after announcing a strategy to expand into oncology.
Jun 30:Moderna announced major updates on an mRNA-based flu vaccine.
Jul 1:Moderna revealed its strategy for using mRNA to combat cancer and rare diseases.

Sentiment: 80% bullish / 20% neutral (early) → 90% bullish / 10% neutral (late)

Impact: The narrative evolved from initial excitement over new product strategies to a strong market rally, highlighting investor optimism in Moderna's future prospects.

Analyst ConsensusHold (27 analysts)

Target: $108 avg (+125% upside)

7 Buy · 16 Hold · 4 Sell

Signal

Bullish

Confidence

80%

Based on curated news sources (not retail comments)

Over the last 7 days: Moderna is experiencing strong market interest and positive developments in its product pipeline.

SentimentCautious Optimism

AnalysisHype

Bullish Factors

✓Moderna's shares rose significantly, hitting a 52-week high after expanding its mRNA platform into new therapeutic areas.
✓Positive market response to new pipeline updates and encouraging influenza vaccine data.

Risk Factors

No bear risks identified

Analyst target

125% upside · 11 analysts · $25–$245 range

▲ $108

Insiders (90d)

0 buys, 7 sells

Last: SELL Aug 5· 21d ago

▼Net selling $35.2M

Rules-based signal view →

Analyze with AI yahoo!finance Reddit Answers